ArticleCurrent oncology (Toronto, Ont.)2024

Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?

Catherine Y Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.